Achieved Q1 2026 PEMGARDA ® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 million; Invivyd in vitro data ...

Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.

TOKYO - The Japanese government on Thursday is set to announce that the current COVID-19 quasi-emergency measures in place ...

With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.

ETHealthworld.com brings latest gagandeep kang news, views and updates from all top sources for the Indian Health industry.

British nationals linked to MV Hondius are being evacuated to the facility that housed Wuhan Covid evacuees as the WHO makes ...

An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of ...

Big boost to India's fight against Covid-19 as Bharat Biotech's vaccine gets approval from Central Drugs Standard Control Organisation (CDSCO). The UK approved the second 'bivalent' booster for the ...

Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.

Almost as soon as the hantavirus outbreak on the cruise ship MV Hondius became international news, public health experts ...